Antineutrophil cytoplasmic autoantibodies (ANCAs) are serologic markers of small-vessel vasculitides, including microscopic polyangiitis, granulomatosis with polyangiitis (Wegener's granulomatosis), and the Churg-Strauss syndrome.1 Since the discovery of ANCAs more than two ...
The Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial (ClinicalTrials.gov number, NCT00000620) was designed primarily to study the effects of intensive glycemic control on cardiovascular events in persons with ...
The history of pharmacologic treatment of obesity is characterized by repetition: most drugs that have achieved regulatory approval and reached the markets have subsequently been withdrawn owing to postmarketing discovery ...
Background Self-identified race or ethnic group is used to determine normal reference standards in the prediction of pulmonary function. We conducted a study to determine whether the genetically determined percentage ...
Background Recently developed technologies for the treatment of type 1 diabetes mellitus include a variety of pumps and pumps with glucose sensors.
Methods In this 1-year, multicenter, randomized, controlled trial, ...
Background We examined the effects of a multicomponent, school-based program addressing risk factors for diabetes among children whose race or ethnic group and socioeconomic status placed them at high risk ...